Virios Therapeutics (VIRI) Short Interest Ratio & Short Volume → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free VIRI Stock Alerts $0.41 +0.00 (+0.86%) (As of 01:35 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Virios Therapeutics Short Interest DataCurrent Short Volume238,500 sharesPrevious Short Volume214,500 sharesChange Vs. Previous Month+11.19%Dollar Volume Sold Short$108,016.65Short Interest Ratio / Days to Cover0.8Last Record DateApril 30, 2024Outstanding Shares19,260,000 sharesPercentage of Shares Shorted1.24%Today's Trading Volume35,174 sharesAverage Trading Volume309,925 sharesToday's Volume Vs. Average11% Short Selling Virios Therapeutics ? Sign up to receive the latest short interest report for Virios Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVIRI Short Interest Over TimeVIRI Days to Cover Over TimeVIRI Percentage of Float Shorted Over Time Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic Virios Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024238,500 shares $108,016.65 +11.2%N/A0.8 $0.45 4/15/2024214,500 shares $101,029.50 -1.4%N/A0.7 $0.47 3/31/2024217,500 shares $104,204.25 +27.8%N/A0.6 $0.48 3/15/2024170,200 shares $54,123.60 +76.9%N/A0.5 $0.32 2/29/202496,200 shares $35,690.20 -36.8%N/A0.4 $0.37 2/15/2024152,300 shares $58,787.80 +67.4%N/A0.6 $0.39 Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202491,000 shares $37,310.00 -59.5%N/A0.3 $0.41 1/15/2024224,900 shares $170,699.10 +1.5%N/A0.5 $0.76 12/31/2023221,600 shares $127,420.00 -12.6%N/A0.5 $0.58 12/15/2023253,400 shares $169,651.30 -13.0%N/A0.6 $0.67 11/30/2023291,100 shares $165,635.90 -35.8%N/A0.7 $0.57 11/15/2023453,700 shares $333,197.28 +308.7%N/A1 $0.73 10/31/2023111,000 shares $61,050.00 -42.7%N/A0.2 $0.55 10/15/2023193,800 shares $154,071.00 -30.4%N/A0.5 $0.80 9/30/2023278,500 shares $257,556.80 -33.4%N/A0.5 $0.92 9/15/2023418,400 shares $435,136.00 -10.0%N/A0.7 $1.04 8/31/2023465,100 shares $511,610.00 -17.9%N/A0.7 $1.10 8/15/2023566,300 shares $577,626.00 -4.0%N/A0.7 $1.02 7/31/2023589,800 shares $1.12 million +16.2%N/A0.8 $1.90 7/15/2023507,600 shares $1.23 million +52.1%N/A0.2 $2.42 6/30/2023333,700 shares $460,506.00 -36.4%N/A0.1 $1.38 6/15/2023524,500 shares $970,325.00 +26.6%N/A0.2 $1.85 5/31/2023414,300 shares $712,596.00 +26.5%N/A0.1 $1.72 5/15/2023327,500 shares $337,325.00 -68.8%N/A0.1 $1.03 4/30/20231,050,000 shares $766,500.00 +95.9%N/A0.4 $0.73 4/15/2023536,100 shares $364,548.00 +45.3%N/A0.2 $0.68 3/31/2023368,900 shares $135,570.75 +0.0%N/A0.6 $0.37 3/15/2023368,800 shares $111,857.04 +52.5%N/A0.8 $0.30 2/28/2023241,900 shares $72,570.00 +18.3%N/A0.6 $0.30 2/15/2023204,500 shares $69,100.55 -23.6%N/A0.6 $0.34 1/31/2023267,700 shares $82,612.22 +25.6%N/A0.8 $0.31 1/15/2023213,100 shares $59,028.70 +4.0%N/A0.7 $0.28 12/30/2022205,000 shares $48,380.00 -42.5%N/A0.7 $0.24 12/15/2022356,400 shares $92,664.00 +20.8%N/A1.1 $0.26 11/30/2022295,100 shares $85,579.00 -33.2%N/A0.4 $0.29 11/15/2022441,500 shares $136,865.00 +55.7%N/A0.6 $0.31 10/31/2022283,600 shares $77,990.00 -34.4%N/A0.4 $0.28 10/15/2022432,600 shares $154,438.20 +8.7%N/A0.7 $0.36 9/30/2022398,100 shares $151,477.05 +526.9%4.8%0.7 $0.38 9/15/202263,500 shares $492,760.00 +18.0%0.8%0.1 $7.76Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. VIRI Short Interest - Frequently Asked Questions What is Virios Therapeutics' current short interest? Short interest is the volume of Virios Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 238,500 shares of VIRI short. Learn More on Virios Therapeutics' current short interest. What is a good short interest ratio for Virios Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIRI shares currently have a short interest ratio of 1.0. Learn More on Virios Therapeutics's short interest ratio. Is Virios Therapeutics' short interest increasing or decreasing? Virios Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 238,500 shares, an increase of 11.2% from the previous total of 214,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Virios Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Virios Therapeutics: Oragenics, Inc. (2.07%), eFFECTOR Therapeutics, Inc. (3.12%), Bionomics Limited (1.45%), Vaxxinity, Inc. (3.61%), Hepion Pharmaceuticals, Inc. (1.19%), Trevena, Inc. (0.08%), Cadrenal Therapeutics, Inc. (0.80%), Shuttle Pharmaceuticals Holdings, Inc. (0.74%), Pasithea Therapeutics Corp. (1.34%), Tenax Therapeutics, Inc. (1.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Virios Therapeutics stock? Short selling VIRI is an investing strategy that aims to generate trading profit from Virios Therapeutics as its price is falling. VIRI shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virios Therapeutics? A short squeeze for Virios Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VIRI, which in turn drives the price of the stock up even further. How often is Virios Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIRI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: OGEN Short Squeeze EFTR Short Squeeze BNOX Short Squeeze VAXX Short Squeeze HEPA Short Squeeze TRVN Short Squeeze CVKD Short Squeeze SHPH Short Squeeze KTTA Short Squeeze TENX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIRI) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research